Total Payments
$75,021
2024 Payments
$7,841
Companies
9
Transactions
90
Medicare Patients
12,933
Medicare Billing
$942,468
Payment Breakdown by Category
Other$72,472 (96.6%)
Food & Beverage$2,138 (2.9%)
Travel$384.70 (0.5%)
Education$25.79 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66,672 | 43 | 88.9% |
| Honoraria | $5,800 | 3 | 7.7% |
| Food and Beverage | $2,138 | 39 | 2.9% |
| Travel and Lodging | $384.70 | 3 | 0.5% |
| Education | $25.79 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $67,132 | 67 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $6,281 | 8 | $0 (2017) |
| Tandem Diabetes Care, Inc. | $1,382 | 6 | $0 (2020) |
| Medtronic, Inc. | $94.48 | 1 | $0 (2023) |
| Amgen Inc. | $60.43 | 4 | $0 (2021) |
| Inspire Medical Systems, Inc. | $29.97 | 1 | $0 (2023) |
| Abbott Laboratories | $17.11 | 1 | $0 (2022) |
| Eisai Inc. | $11.90 | 1 | $0 (2018) |
| Lilly USA, LLC | $11.05 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,841 | 8 | Novo Nordisk Inc ($7,841) |
| 2023 | $10,786 | 10 | Novo Nordisk Inc ($10,661) |
| 2022 | $18,207 | 16 | Novo Nordisk Inc ($18,190) |
| 2021 | $17,725 | 22 | Novo Nordisk Inc ($17,685) |
| 2020 | $12,833 | 18 | Novo Nordisk Inc ($12,739) |
| 2019 | $1,020 | 5 | Tandem Diabetes Care, Inc. ($1,000) |
| 2018 | $328.56 | 3 | Tandem Diabetes Care, Inc. ($300.00) |
| 2017 | $6,281 | 8 | Orexigen Therapeutics, Inc. ($6,281) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,687.50 | General |
| 05/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $85.29 | General |
| 04/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,754.50 | General |
| Category: Diabetes | ||||||
| 11/21/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Diabetes | ||||||
| 11/03/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 08/18/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Diabetes | ||||||
| 07/10/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: NEUROLOGY | ||||||
| 06/28/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 06/27/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Diabetes | ||||||
| 06/21/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $94.48 | General |
| Category: Durable Pump | ||||||
| 04/18/2023 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,914.00 | General |
| 03/08/2023 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,437.50 | General |
| 03/08/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.58 | General |
| 11/15/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 11/15/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| 11/09/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $103.30 | General |
| 10/31/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $794.75 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes Care | ||||||
| 08/17/2022 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,367 | 20,282 | $464,699 | $306,915 |
| 2022 | 37 | 3,155 | 7,891 | $310,590 | $198,260 |
| 2021 | 36 | 3,395 | 8,327 | $338,236 | $218,685 |
| 2020 | 30 | 3,016 | 15,078 | $359,633 | $218,607 |
Total Patients
12,933
Total Services
51,578
Medicare Billing
$942,468
Procedure Codes
139
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 18 | 11,550 | $120,480 | $89,851 | 74.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 560 | 925 | $146,059 | $81,037 | 55.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 42 | 4,140 | $99,510 | $75,403 | 75.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $14,504 | $6,305 | 43.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 277 | 412 | $6,700 | $5,405 | 80.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 85 | $10,115 | $5,393 | 53.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 339 | 545 | $6,951 | $5,181 | 74.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 339 | 496 | $7,490 | $5,134 | 68.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 70 | 70 | $6,210 | $5,035 | 81.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 208 | 273 | $7,686 | $4,494 | 58.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 31 | $7,161 | $4,057 | 56.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 88 | 98 | $3,430 | $2,843 | 82.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 74 | 74 | $2,555 | $2,226 | 87.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 72 | 80 | $4,348 | $2,078 | 47.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 158 | $4,740 | $1,703 | 35.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 192 | 248 | $2,243 | $1,404 | 62.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 192 | 248 | $1,612 | $1,260 | 78.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 23 | 28 | $1,736 | $1,133 | 65.2% |
| 84436 | Thyroxine (thyroid chemical), total | Office | 2023 | 128 | 163 | $1,425 | $1,097 | 77.0% |
| 84479 | Thyroid hormone evaluation | Office | 2023 | 128 | 163 | $1,321 | $1,033 | 78.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 31 | 34 | $2,108 | $859.86 | 40.8% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 30 | 33 | $825.00 | $702.90 | 85.2% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 89 | 103 | $824.00 | $653.02 | 79.3% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 32 | 37 | $629.00 | $514.30 | 81.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 30 | 32 | $576.00 | $472.96 | 82.1% |
About Dr. Ben Phillips, MD
Dr. Ben Phillips, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245276997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ben Phillips, MD has received a total of $75,021 in payments from pharmaceutical and medical device companies, with $7,841 received in 2024. These payments were reported across 90 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($66,672).
As a Medicare-enrolled provider, Phillips has provided services to 12,933 Medicare beneficiaries, totaling 51,578 services with total Medicare billing of $942,468. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Midlothian, VA
- Active Since 06/21/2006
- Last Updated 08/19/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1245276997
Products in Payments
- RYBELSUS (Drug) $20,237
- Ozempic (Drug) $19,241
- Rybelsus (Drug) $19,095
- CONTRAVE (Drug) $6,281
- t-slim insulin pump (Device) $1,300
- MINIMED 780G (Device) $94.48
- t:slim X2 insulin pump (Device) $82.40
- EVENITY (Biological) $46.54
- INSPIRE (Device) $29.97
- FREESTYLE LIBRE (Device) $17.11
- Belviq (Drug) $11.90
- LYUMJEV (Drug) $11.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Midlothian
Mrs. Meredith Berger, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $95,976
Endocrinology, Diabetes & Metabolism $95,976
Dr. Maria Renela Suller, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $15,076
Endocrinology, Diabetes & Metabolism $15,076
Mrs. Christina Wagner, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $10,825
Endocrinology, Diabetes & Metabolism $10,825
Dr. Matthew Laroe, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $5,282
Endocrinology, Diabetes & Metabolism $5,282
Mrs. Helen Kuno, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $4,960
Endocrinology, Diabetes & Metabolism $4,960
Charisse Hanne Te, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,907
Endocrinology, Diabetes & Metabolism $3,907